AUDIT

The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item self-report screening instrument developed by the World Health Organization to identify hazardous drinking, harmful alcohol use, and alcohol dependence. Items cover alcohol consumption (3 items), drinking behavior and dependence (3 items), and alcohol-related problems (4 items), each scored 0–4, yielding total scores from 0 to 40. A score of 8 or above indicates hazardous or harmful alcohol use. The AUDIT is the primary screening and outcome measure in psilocybin-assisted therapy trials for alcohol use disorder, including the landmark NYU trial led by Michael Bogenschutz demonstrating significant reductions in heavy drinking days after psilocybin treatment. It has excellent sensitivity (92%) and specificity (94%) for identifying hazardous drinking and is validated in over 40 languages.